GL1X · GenesisL1 explorer

Research workbench

HIV-1 integrase core domain in complex with 2,1,3-benzothiadiazol-4- amine

Analyse HIV-1 integrase core domain in complex with 2,1,3-benzothiadiazol-4- amine in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3VQQ
Type
protein
Length
284 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Pol polyprotein
UniProt
Q72498
Ligands
BTE, GLC, FRU, CD, SO4
Pockets
5 · best druggability 0.51

Structure

x-ray diffraction · 2 distinct chains · 46% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APol polyproteinprotein14444% helix, 25% strandQ72498
BPol polyproteinprotein14047% helix, 21% strandQ72498

Ligands and binding sites

  • BTE · 2,1,3-benzothiadiazol-4-amine · ligand · 2 copies · chains A, B
  • GLC · alpha-D-glucopyranose · sugar · chains A, B
  • FRU · beta-D-fructofuranose · sugar · chains A, B
  • CD · Cadmium ion · metal · 4 copies · chains A, B
  • SO4 · Sulfate ion · ion · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11110.510.8123BTE
21610.510.7819GLC, FRU
3630.450.8317BTE
4940.440.7916empty
5630.420.8114empty

Interfaces

1 interface between chains.

  • A–B · 1603 Ų buried · 23 hydrogen bonds · protein-protein

Compared structures

  • 3VQQ · HIV-1 integrase core domain in complex with 2,1,3-benzothiadiazol-4-amine · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.